Sabetta James R MD is categorized under Infectious Disease Specialists in Greenwich, CT and active since 1996.
Sabetta James R MD was established in 1996, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Infectious Disease Specialists business, which does work in the B2C market, and is classified as a Infectious Disease Specialists, under code number 6211110 by the NAICS.
If you are seeking more information, feel free to contact James Sabetta at the company’s single location by writing to 5 Perryridge Road, Greenwich, Connecticut CT 06830 or by phoning (203) 869-8838. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Sabetta James R MD |
| Contact Person: | James Sabetta |
| Address: | 5 Perryridge Road, Greenwich, Connecticut 06830 |
| Phone Number: | (203) 869-8838 |
| Website Address: | greenhosp.org |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1996 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Infectious Disease Specialists |
| SIC Code: | 8011 |
| NAICS Code: | 6211110 |
| Share This Business: |
Sabetta James R MD was started in 1996 to provide professional Infectious Disease Specialists under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact James Sabetta for inquiries that concern Sabetta James R MD by calling the company number (203) 869-8838, as your correspondence is most welcome. Additionally, the physical location of the single location of Sabetta James R MD can be found at the coordinates 41.03467,-73.62958 as well as the street address 5 Perryridge Road in Greenwich, Connecticut 06830.
For its online presence, you may visit Sabetta James R MD’s website at greenhosp.org and engage with its social media outlets through on Twitter and on Facebook.